Literature DB >> 21113180

Chronic and acute infection of the gall bladder by Salmonella Typhi: understanding the carrier state.

Geoffrey Gonzalez-Escobedo1, Joanna M Marshall, John S Gunn.   

Abstract

Despite major treatment and prevention efforts, millions of new typhoid infections occur worldwide each year. For a subset of infected individuals, Salmonella enterica subsp. enterica serovar Typhi colonizes the gall bladder and remains there long after symptoms subside, serving as a reservoir for the further spread of the disease. In this Progress article, we explore recent advances in our understanding of the mechanisms by which Salmonella spp.--predominantly S. Typhi--colonize and persist in the human gall bladder.

Entities:  

Mesh:

Year:  2010        PMID: 21113180      PMCID: PMC3255095          DOI: 10.1038/nrmicro2490

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  81 in total

1.  Does Salmonella Typhi primarily reside in the liver of chronic typhoid carriers?

Authors:  Gopal Nath; Yogesh Kumar Singh; Pushpa Maurya; Anil Kumar Gulati; Ramit C Srivastava; Sunil Kumar Tripathi
Journal:  J Infect Dev Ctries       Date:  2010-02-03       Impact factor: 0.968

2.  Dissemination of invasive Salmonella via bacterial-induced extrusion of mucosal epithelia.

Authors:  Leigh A Knodler; Bruce A Vallance; Jean Celli; Seth Winfree; Bryan Hansen; Marinieve Montero; Olivia Steele-Mortimer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

3.  Salmonella typhi carrier state 52 years after illness with typhoid fever: a case study.

Authors:  J S Shpargel; R S Berardi; D Lenz
Journal:  Am J Infect Control       Date:  1985-06       Impact factor: 2.918

4.  Studies on infection and immunity in experimental typhoid fever. VII. The distribution of Salmonella typhi in chimpanzee tissue following oral challenge, and the relationship between the numbers of bacilli and morphologic lesions.

Authors:  S Gaines; H Sprinz; J G Tully; W D Tigertt
Journal:  J Infect Dis       Date:  1968-06       Impact factor: 5.226

5.  Pivmecillinam in the treatment of Salmonella carriers.

Authors:  M Jonsson
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

Review 6.  Cholelithiasis and cholecystitis.

Authors:  Bruce D Schirmer; Kathryne L Winters; Richard F Edlich
Journal:  J Long Term Eff Med Implants       Date:  2005

Review 7.  Roles of infection, inflammation, and the immune system in cholesterol gallstone formation.

Authors:  Kirk J Maurer; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2008-12-25       Impact factor: 22.682

8.  Association of carcinoma of the gallbladder with typhoid carriage in a typhoid endemic area using nested PCR.

Authors:  Gopal Nath; Yogesh Kumar Singh; Kailash Kumar; Anil Kumar Gulati; Vijay Kumar Shukla; Ajay Kumar Khanna; Sunil Kumar Tripathi; Ashok Kumar Jain; Mohan Kumar; Tej Bali Singh
Journal:  J Infect Dev Ctries       Date:  2008-08-30       Impact factor: 0.968

Review 9.  Acute acalculous cholecystitis: a review.

Authors:  Jason L Huffman; Steven Schenker
Journal:  Clin Gastroenterol Hepatol       Date:  2009-09-10       Impact factor: 11.382

10.  Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be reactivated by IFNgamma neutralization.

Authors:  Denise M Monack; Donna M Bouley; Stanley Falkow
Journal:  J Exp Med       Date:  2004-01-19       Impact factor: 14.307

View more
  112 in total

Review 1.  Gallbladder cancer.

Authors:  Mislav Rakić; Leonardo Patrlj; Mario Kopljar; Robert Kliček; Marijan Kolovrat; Bozo Loncar; Zeljko Busic
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  Antimicrobial resistance in Salmonella spp. recovered from patients admitted to six different hospitals in Tehran, Iran from 2007 to 2008.

Authors:  Mercedeh Tajbakhsh; Rene S Hendriksen; Zahra Nochi; Mohammad Reza Zali; Frank M Aarestrup; Lourdes Garcia-Migura
Journal:  Folia Microbiol (Praha)       Date:  2012-02-04       Impact factor: 2.099

3.  Pathoadaptive Alteration of Salmonella Biofilm Formation in Response to the Gallbladder Environment.

Authors:  Michael R Neiger; Juan F González; Geoffrey Gonzalez-Escobedo; Harkness Kuck; Peter White; John S Gunn
Journal:  J Bacteriol       Date:  2019-06-21       Impact factor: 3.490

4.  Human Bile-Mediated Regulation of Salmonella Curli Fimbriae.

Authors:  Juan F González; Lauren Tucker; James Fitch; Amy Wetzel; Peter White; John S Gunn
Journal:  J Bacteriol       Date:  2019-08-22       Impact factor: 3.490

5.  Gallbladder epithelium as a niche for chronic Salmonella carriage.

Authors:  Geoffrey Gonzalez-Escobedo; John S Gunn
Journal:  Infect Immun       Date:  2013-06-03       Impact factor: 3.441

Review 6.  Salmonella chronic carriage: epidemiology, diagnosis, and gallbladder persistence.

Authors:  John S Gunn; Joanna M Marshall; Stephen Baker; Sabina Dongol; Richelle C Charles; Edward T Ryan
Journal:  Trends Microbiol       Date:  2014-07-22       Impact factor: 17.079

Review 7.  Genomic overview and biological functions of exopolysaccharide biosynthesis in Bifidobacterium spp.

Authors:  Claudio Hidalgo-Cantabrana; Borja Sánchez; Christian Milani; Marco Ventura; Abelardo Margolles; Patricia Ruas-Madiedo
Journal:  Appl Environ Microbiol       Date:  2013-10-11       Impact factor: 4.792

Review 8.  Persistent Infection and Long-Term Carriage of Typhoidal and Nontyphoidal Salmonellae.

Authors:  Ohad Gal-Mor
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

Review 9.  Helicobacter and salmonella persistent infection strategies.

Authors:  Denise M Monack
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

Review 10.  Survival of the Fittest: How Bacterial Pathogens Utilize Bile To Enhance Infection.

Authors:  Jeticia R Sistrunk; Kourtney P Nickerson; Rachael B Chanin; David A Rasko; Christina S Faherty
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.